{"id":"https://openalex.org/W1997181256","doi":"https://doi.org/10.1080/15257779908041535","title":"Synthesis of Alkenyl Acyclonucleosides Derivatives of 5-Halogenouracil as Antiviral and Antitumoral Agents","display_name":"Synthesis of Alkenyl Acyclonucleosides Derivatives of 5-Halogenouracil as Antiviral and Antitumoral Agents","publication_year":1999,"publication_date":"1999-04-01","ids":{"openalex":"https://openalex.org/W1997181256","doi":"https://doi.org/10.1080/15257779908041535","mag":"1997181256","pmid":"https://pubmed.ncbi.nlm.nih.gov/10432662"},"language":"en","primary_location":{"id":"doi:10.1080/15257779908041535","doi":"https://doi.org/10.1080/15257779908041535","is_oa":false,"landing_page_url":"https://doi.org/10.1080/15257779908041535","pdf_url":null,"source":{"id":"https://openalex.org/S4210177795","display_name":"Nucleosides and Nucleotides","issn_l":"0732-8311","issn":["0732-8311","2332-3892"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nucleosides and Nucleotides","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111608239","display_name":"A. Rochdi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I119856527","display_name":"Cadi Ayyad University","ror":"https://ror.org/04xf6nm78","country_code":"MA","type":"education","lineage":["https://openalex.org/I119856527"]}],"countries":["MA"],"is_corresponding":false,"raw_author_name":"A. Rochdi","raw_affiliation_strings":["Laboratoire de Chimie Bio-Organique, Facult\u00e9 des Sciences Semlalia, Marrakech, Maroc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Chimie Bio-Organique, Facult\u00e9 des Sciences Semlalia, Marrakech, Maroc","institution_ids":["https://openalex.org/I119856527"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058943643","display_name":"Moha Taourirte","orcid":"https://orcid.org/0000-0002-5691-1386","observed_orcids":["https://orcid.org/0000-0002-5691-1386"]},"institutions":[{"id":"https://openalex.org/I119856527","display_name":"Cadi Ayyad University","ror":"https://ror.org/04xf6nm78","country_code":"MA","type":"education","lineage":["https://openalex.org/I119856527"]}],"countries":["MA"],"is_corresponding":false,"raw_author_name":"M. Taourirte","raw_affiliation_strings":["D\u00e9partement de Chimie, Facult\u00e9 des Sciences et Techniques Gueliz, Marrakech, Maroc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Chimie, Facult\u00e9 des Sciences et Techniques Gueliz, Marrakech, Maroc","institution_ids":["https://openalex.org/I119856527"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050167064","display_name":"Nezha Redwane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I119856527","display_name":"Cadi Ayyad University","ror":"https://ror.org/04xf6nm78","country_code":"MA","type":"education","lineage":["https://openalex.org/I119856527"]}],"countries":["MA"],"is_corresponding":false,"raw_author_name":"N. Redwane","raw_affiliation_strings":["Laboratoire de Chimie Bio-Organique, Facult\u00e9 des Sciences Semlalia, Marrakech, Maroc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Chimie Bio-Organique, Facult\u00e9 des Sciences Semlalia, Marrakech, Maroc","institution_ids":["https://openalex.org/I119856527"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054174443","display_name":"Hassan Bihi Lazrek","orcid":"https://orcid.org/0000-0002-3849-9092","observed_orcids":["https://orcid.org/0000-0002-3849-9092"]},"institutions":[{"id":"https://openalex.org/I119856527","display_name":"Cadi Ayyad University","ror":"https://ror.org/04xf6nm78","country_code":"MA","type":"education","lineage":["https://openalex.org/I119856527"]}],"countries":["MA"],"is_corresponding":false,"raw_author_name":"H. B. Lazrek","raw_affiliation_strings":["Laboratoire de Chimie Bio-Organique, Facult\u00e9 des Sciences Semlalia, Marrakech, Maroc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Chimie Bio-Organique, Facult\u00e9 des Sciences Semlalia, Marrakech, Maroc","institution_ids":["https://openalex.org/I119856527"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110067421","display_name":"J. L. Barascut","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387154756","display_name":"Universit\u00e9 Montpellier 2","ror":"https://ror.org/00wh4bp03","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307","https://openalex.org/I4387154756"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J. L. Barascut","raw_affiliation_strings":["Laboratoire de Chimie Bio-Organique, U.S.T.L., Montpellier II, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Chimie Bio-Organique, U.S.T.L., Montpellier II, France","institution_ids":["https://openalex.org/I4387154756"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111961339","display_name":"Jean Louis Imbach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387154756","display_name":"Universit\u00e9 Montpellier 2","ror":"https://ror.org/00wh4bp03","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307","https://openalex.org/I4387154756"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J. L. Imbach","raw_affiliation_strings":["Laboratoire de Chimie Bio-Organique, U.S.T.L., Montpellier II, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Chimie Bio-Organique, U.S.T.L., Montpellier II, France","institution_ids":["https://openalex.org/I4387154756"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2922,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.47185759,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"18","issue":"4-5","first_page":"673","last_page":"674"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.4982999861240387,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.4982999861240387,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.21220000088214874,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.11259999871253967,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/michael-addition","display_name":"Michael addition","score":0.7369999885559082},{"id":"https://openalex.org/keywords/antiviral-agents","display_name":"antiviral agents","score":0.8519999980926514},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.9449999928474426},{"id":"https://openalex.org/keywords/allyl-bromide","display_name":"allyl bromide","score":0.9129999876022339},{"id":"https://openalex.org/keywords/ethyl-bromoacetate","display_name":"ethyl bromoacetate","score":0.8870000243186951},{"id":"https://openalex.org/keywords/nucleoside-analogs","display_name":"nucleoside analogues","score":0.699999988079071}],"concepts":[{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.37750905752182007},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3725574016571045},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3635921776294708},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3584594130516052},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.28921937942504883}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009682","descriptor_name":"Magnetic Resonance Spectroscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009705","descriptor_name":"Nucleosides","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D009705","descriptor_name":"Nucleosides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1080/15257779908041535","doi":"https://doi.org/10.1080/15257779908041535","is_oa":false,"landing_page_url":"https://doi.org/10.1080/15257779908041535","pdf_url":null,"source":{"id":"https://openalex.org/S4210177795","display_name":"Nucleosides and Nucleotides","issn_l":"0732-8311","issn":["0732-8311","2332-3892"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nucleosides and Nucleotides","raw_type":"journal-article"},{"id":"pmid:10432662","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10432662","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nucleosides & nucleotides","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.5683000087738037,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W1994689531","https://openalex.org/W2048884660","https://openalex.org/W2050385038","https://openalex.org/W2058968801","https://openalex.org/W2402715082","https://openalex.org/W2883903927"],"related_works":["https://openalex.org/W2949742522","https://openalex.org/W2072220244","https://openalex.org/W2952987024","https://openalex.org/W1979951762","https://openalex.org/W2951459390","https://openalex.org/W2119099433","https://openalex.org/W4236411872","https://openalex.org/W2949787931","https://openalex.org/W2952262871","https://openalex.org/W2164057100"],"abstract_inverted_index":{"Alkenyl":[0],"acyclonucleosides":[1],"derivatives":[2],"of":[3],"5-halogenouracil":[4],"have":[5],"been":[6],"synthesized":[7],"via":[8],"Michael":[9],"addition":[10],"reaction.":[11],"These":[12],"compounds":[13],"were":[14],"treated":[15],"by":[16],"allylbromide,":[17],"propargylbromide":[18],"or":[19],"ethylbromoacetate":[20],"to":[21],"give":[22],"the":[23],"corresponding":[24],"N-1,N-3-disubstituted":[25],"5-halogenouracil.":[26]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}